 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
# r& s; L* `' y" c$ P: F9 Y * R+ d- R/ @3 \; j( U+ ~
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
% O$ b g$ d" ]) D* ?
- o- c( k4 R9 xBY THE EDMONTON JOURNAL FEBRUARY 16, 2007& [* o4 L8 h: L: p" v4 Q) d
( F- E G6 P3 G2 K5 v) R
0 V, F/ r2 g7 n9 O; ]# G8 m+ ~* N3 z
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
) {0 r a& V1 R* O8 R. T( }& `- v7 `8 U! D' |% E. ]
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
: w& B- A$ S" V4 S2 s/ a0 y- A/ O: P' j+ e% i; k- i; @+ n
The APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
* m. [; `3 @; B% {8 J
% ]% ]- r: m; k- \It should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
& } K( `8 L/ h: K
) q3 `3 S& P- ?4 dIt certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.6 N# q9 Y- n. |
* C, \* m8 z+ R$ G- V9 N0 r
"As a scientist, it's one of the highlights of my CAREER," Shan said.
v$ c" ~& H; J, I& n2 i6 R- V# R% _4 f, k
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."' n5 B0 ^8 z9 t4 n& N# `! b; D
Y8 s% i& t `0 X
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.7 w1 R5 u2 @( j& H
1 l1 T) O7 |3 G2 P, u, qGinseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth./ }2 q& r4 h/ y" t, t/ P9 T
/ I& ?+ R( Z: z) u+ |% q
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman./ H2 o4 ]; P; |
' B# z4 [" P2 `% [) ?( X
; u# _3 J, m2 q$ W( G; `! \. f' o
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|